Rocket Lab CFO Adam Spice sells 140,157 shares
The option's vesting schedule provided for one-quarter of shares to vest on the one-year anniversary, then 1/48 monthly, subject to continued service.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Rocket Lab Corp (RKLB) Chief Financial Officer Adam C. Spice exercised options covering 140,157 common shares on November 2, 2026, at an exercise price of $1.09 per share, and sold 140,157 shares in five reported transactions. The sales occurred automatically under a Rule 10b5-1 trading plan he adopted on June 3, 2026. The five weighted-average sale prices were $51.2804, $52.2638, $53.2884, $54.0728, and $54.7849 per share. After the exercise, his reported employee stock option position covered 2,102,354 shares; his reported holdings also include 250,000 common shares held indirectly by a trust.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) F7 | 140,157 | $0.00 | $0.00 |
| Exercise | Common Stock | 140,157 | $1.09 | $153K |
| Sale | Common Stock F1, F2 | 47,554 | $51.2804 | $2.44M |
| Sale | Common Stock F1, F3 | 14,266 | $52.2638 | $746K |
| Sale | Common Stock F1, F4 | 33,681 | $53.2884 | $1.79M |
| Sale | Common Stock F1, F5 | 37,950 | $54.0728 | $2.05M |
| Sale | Common Stock F1, F6 | 6,706 | $54.7849 | $367K |
| Holding | Common Stock | -- | -- | -- |
Footnotes (7)
- F1. Represents the sale of shares which occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 03, 2026.
- F2. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $50.7100 to $51.7000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $51.7100 to $52.7000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $52.7100 to $53.7000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $53.7100 to $54.7000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $54.7100 to $55.0000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7. The stock option was granted on August 3, 2018, and had a vesting commencement date of May 25, 2018. 1/4 of the shares subject to the stock option vest on the one year anniversary of the vesting commencement date, and 1/48 of the shares subject to the stock option vest on a monthly basis each month thereafter, subject, in each case, to the reporting person's continued service relationship through each applicable vesting date.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted-average price financial
vesting commencement date financial
exercise price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were the vesting terms for Adam C. Spice's RKLB option?
AI-generated analysis. How Rhea-AI works. Not financial advice.